DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Farooqui MZ, Valdez J, Martyr S. et al.
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

Lancet Oncol 2015;
16: 169-176

Download Bibliographical Data

Search in:
Access: